Literature DB >> 16462132

Proton MR spectroscopy of adult-onset dentatorubral-pallidoluysian atrophy.

Tesseki Kin1, Makito Hirano, Toshiaki Taoka, Miwa Takamure, Yoshiko Furiya, Kimihiko Kichikawa, Satoshi Ueno.   

Abstract

PURPOSE: To quantify impairment of the basal ganglia (globus pallidus and thalamus) in adult-onset dentatorubral-pallidoluysian atrophy (DRPLA).
METHODS: Five patients with genetically definite adult-onset DRPLA (aged 51 to 65 years, mean 55.6 years) and 5 age- and sex-matched healthy controls underwent conventional magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (MRS) of the brain in the voxels predominantly containing the globus pallidus or the thalamus.
RESULTS: Conventional MRI studies showed apparently normal intensities in the globus pallidus and thalamus. MRS showed that the choline (Cho)/creatine (Cr) ratio for the patients' globus pallidus, the region preferentially affected in DRPLA, was significantly higher than that in the controls (p<0.05). The N-acetylaspartate (NAA)/Cr ratio for the globus pallidus and the Cho/Cr and NAA/Cr ratios for the thalamus, the region relatively spared in this disease, did not differ significantly between the patients and controls.
CONCLUSIONS: MRS may sensitively and specifically detect biochemical alterations in susceptible regions of patients with adult-onset DRPLA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16462132     DOI: 10.2463/mrms.4.123

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  2 in total

1.  Radiologic and neuropathologic findings in patients in a family with dentatorubral-pallidoluysian atrophy.

Authors:  Y Sunami; R Koide; N Arai; M Yamada; T Mizutani; K Oyanagi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

Review 2.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.